A biotech company conducted a Phase 1/2 clinical trial in Cambridge.

The entities involved

• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• Cambridge →

  city in Middlesex County, Massachusetts, United States of America

  • A book featuring Alice Hoffman is set in Cambridge during the 1950s.Sun 13:14
  • MIT operates within the city of Cambridge.Sat 03:12

Related events

• FDA placed a clinical hold on Phase 2/3 trials for SK Biopharm on September 1, 2026.Sep 15
• SynAct Pharma AB is seeking discussion with the FDA regarding the design of its Phase 3 clinical trials.Sep 7
• TELIX Pharmaceuticals is conducting Phase 3 trials and seeking alignment on the New Drug Application pathway with the FDA.Sep 2
• NewcelX Ltd. advanced its IND-enabling work for a Phase 1/2a trial and held a successful Type B Pre-IND meeting with the FDA.Mon 14:50
• Emmaus Life Sciences is conducting Phase 3 trials for an Endari drug, preceding future FDA submission.Sep 14